Ledger.Open graph →

SEC Form D · filed November 10, 2016

Biohaven Pharmaceutical Holding Co Ltd

Offering

$80.0M

Sold

$40.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

New Haven, CT

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

John Tilton · New Haven, CTExec John Childs · New Haven, CTDirector Robert Berman, M.D · New Haven, CTExec Jim Engelhart · New Haven, CTExec Declan Doogan · Stonington, CTDirector Vladimir Coric, M.D · New Haven, CTExec · Director Kimberly Gentile · New Haven, CTExec Greg Bailey · San Francisco, CADirector Kam Shah · New Haven, CTDirector John Tilton · New Haven, CTExec Robert Berman, M.D · New Haven, CTExec Jim Engelhart · New Haven, CTExec Declan Doogan · New Haven, CTDirector Vladimir Coric, M.D · New Haven, CTExec · Director Kimberly Gentile · New Haven, CTExec John Childs · New Haven, CTDirector Greg Bailey · Medford, MADirector Kam Shah · New Haven, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗